Literature DB >> 3029554

Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus.

B Wahren, S Nordlund, A Akesson, V A Sundqvist, B Morein.   

Abstract

Cell-mediated and humoral responses to cytomegalovirus were studied in a monkey model. Repeated low doses of virus antigen gave poor reactivities in both respects. High antigen doses gave a good humoral IgG response. When autologous monocytes were incubated with the CMV antigen as the immunizing injection, the specific cellular response to CMV antigen increased. The monocytes themselves did not contribute to the in vitro specific proliferation response. When iscoms were the carrier particles for CMV antigens, cellular response was even more strongly enhanced. In immunization schedules where specific cellular responses are important, we suggest that autologous monocytes or iscoms may be employed as antigen carriers.

Mesh:

Substances:

Year:  1987        PMID: 3029554     DOI: 10.1007/BF00189404

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  17 in total

Review 1.  Antigen-presenting function of the macrophage.

Authors:  E R Unanue
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

2.  An interchangeable ELISA for cytomegalovirus antigen and antibody.

Authors:  V A Sundqvist; B Wahren
Journal:  J Virol Methods       Date:  1981-04       Impact factor: 2.014

3.  Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.

Authors:  G V Quinnan; N Kirmani; A H Rook; J F Manischewitz; L Jackson; G Moreschi; G W Santos; R Saral; W H Burns
Journal:  N Engl J Med       Date:  1982-07-01       Impact factor: 91.245

4.  Cytomegalovirus infection of human blood cells.

Authors:  L Einhorn; A Ost
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

5.  Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.

Authors:  G A Linde; L Hammarström; M A Persson; C I Smith; V A Sundqvist; B Wahren
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

6.  Inhibition of cytomegalovirus late antigens by phosphonoformate.

Authors:  B Wahren; B Oberg
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

7.  Enhancive and suppressive effects of cytomegalovirus on human lymphocyte responses in vitro.

Authors:  B Wahren; P Ljungman; T Paulin; O Ringdén
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

8.  Cytomegalovirus-specific lymphocyte proliferation and in vitro cytomegalovirus IgG synthesis for diagnosis of cytomegalovirus infections after bone marrow transplantation.

Authors:  P Ljungman; B Lönnqvist; G Gahrton; O Ringdén; B Wahren
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

9.  Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

10.  Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products.

Authors:  G P Rice; R D Schrier; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

View more
  3 in total

1.  Immunogenic properties of ISCOM prepared with influenza virus nucleoprotein.

Authors:  H P Weiss; L Stitz; H Becht
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.

Authors:  B Wahren; L Morfeldt-Månsson; G Biberfeld; L Moberg; A Sönnerborg; P Ljungman; A Werner; R Kurth; R Gallo; D Bolognesi
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

3.  Incorporation of the major outer membrane protein of Neisseria gonorrhoeae in saponin-lipid complexes (iscoms): chemical analysis, some structural features, and comparison of their immunogenicity with three other antigen delivery systems.

Authors:  G F Kersten; T Teerlink; H J Derks; A J Verkleij; T L van Wezel; D J Crommelin; E C Beuvery
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.